HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute
You are here: Home / Archives for HEOR Feature

JCPH’s Nash Discusses Return to Normalcy After First Wave of COVID-19

Jefferson College of Public Health Founding Dean Emeritus David Nash says testing will be key as the U.S. looks to return to normalcy after the initial wave of COVID-19. "I don't know if anybody has the right answers here," he said. "Testing, more testing and even more testing. That is the key […]

more info 04/21/2020View Related Articles
Bookmark and Share

Report: Remdesivir Trials Posting Promising Results

Gilead's COVID-19 treatment, remdesivir, is showing some promise in clinical trials which have seen swift recoveries of symptoms in severe COVID-19 patients, according to a STAT report. According to the report, Gilead's two Phase 3 trials involved 125 patients, 113 of whom were severe cases. The […]

more info 04/20/2020View Related Articles
Bookmark and Share

Frakt, Stevens Seek Input on Planned Survey on Post-Pandemic Predictions

Rob Stevens and Austin Frakt are developing a survey on predictions for post-pandemic behavior and trends, and have asked for input as they work to develop questions. Read more on The Incidental Economist by clicking here. […]

more info 04/19/2020View Related Articles
Bookmark and Share

NHC Launches Online Value Classroom

The National Health Council (NHC) recently announced the launch of the Value Classroom, a new online learning platform aimed at helping patients find their voice in value discussions. "These resources are intended to help patients and patient advocates engage in discussions on and the assessment […]

more info 04/18/2020View Related Articles
Bookmark and Share

HealthCore’s Beachler, Lanes Talk Bolstering RWE with New Tech

In the latest tHEORetically Speaking blog post, HealthCore's Daniel Beachler, Safety & Epidemiology associate director, and Stephen Lanes, Safety & Epidemiology principal epidemiologist, outline how innovative technologies could be used to bolster real-world evidence in precision […]

more info 04/17/2020View Related Articles
Bookmark and Share

ICER Names Venable VP of Patient Engagement

The Institute for Clinical and Economic Review (ICER) announced the appointment of Yvette Venable as its first-ever vice president of patient engagement. ICER in a press release says Venable brings to the table 20-plus years of experience in patient advocacy, health policy and biopharma […]

more info 04/16/2020View Related Articles
Bookmark and Share

Health Care Industry Leveraging RWD to Combat COVID-19

The health care industry is looking to better leverage real-world data in the midst of the COVID-19 pandemic as it looks to get ahead of the virus, according to a Health IT Analytics report. According to the report, leaders are looking to a range of data sources to glean key insights, including […]

more info 04/15/2020View Related Articles
Bookmark and Share

Program Looks to Address Gaps in COVID-19 Data

The Robert Wood Johnson Foundation's Health Data for Action program is supporting a collaboration between Health Care Cost Institute (HCCI), CareJourney and the Berkeley Research Group in an effort to fill in the gaps in COVID-19 data. AcademyHealth manages the Health Data for Action […]

more info 04/14/2020View Related Articles
Bookmark and Share

Clayton-Welch: Quality, Speed, Compliance Key in Dynamic Market Access Landscape

In the second of her five-part series on digital transformation in market access, HealthEconomics.Com© LLC CEO Patti Peeples sits down with PRMA Consulting's Sophie Clayton-Welch to discuss three ways that new technology is helping market access professionals gain cost-effective, real-time payer […]

more info 04/13/2020View Related Articles
Bookmark and Share

Prime Therapeutics Initiative Aims to Help Plan Sponsors Pay for Gene Therapies

The new PreserveRx program from Prime Therapeutics looks to help plan sponsors deal with high-cost gene therapies, Fierce Healthcare reports. According to the report, members of the new program will pay a monthly fee in order to be protected from the crippling costs of expensive drugs like […]

more info 04/13/2020View Related Articles
Bookmark and Share

HealthEconomics.Com, Scientist.Com Announce HEOR, RWE Partnership

HealthEconomics.Com© LLC and Scientist.Com are partnering to streamline HEOR and real-world evidence sourcing in the global HEOR and RWE community and pharma market with the new HEOR & RWE Marketplace. The marketplace offers stakeholders an online platform to both evaluate and purchase HEOR […]

more info 04/10/2020View Related Articles
Bookmark and Share

Blog Post Highlights Impact Coronavirus Could Have on New Drug Launches

A recent blog post on Tribeca Knowledge outlines some of the key challenges pharmaceutical companies face regarding drug launches in the midst of the COVID-19 pandemic. Drug launches outside the COVID-19 arena "are under threat of delay, postponement, dilution or worse," the author, Andre Moa, […]

more info 04/08/2020View Related Articles
Bookmark and Share

Shkreli Seeks Furlough to Research Potential COVID-19 Treatments

Disgraced biotech entrepreneur Martin Shkreli is requesting a 3-month furlough to research potential treatments for COVID-19, STAT reports. In a scientific paper published online, Shkreli lays out how he could contribute to the pandemic response. "As a successful two-time biopharma […]

more info 04/07/2020View Related Articles
Bookmark and Share

ISPOR 2020 Goes Virtual

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is moving its annual meeting into the virtual space in response to the COVID-19 pandemic, the society announced Monday, April 6. According to the announcement, the online event will kick off May 18. ISPOR says the […]

more info 04/06/2020View Related Articles
Bookmark and Share

AMCP to Supreme Court: Ruling Against PCMA Could Raise Health Costs

The Academy of Managed Care Pharmacy (AMCP) in an amicus brief filed in the Supreme Court tells the court ruling against the Pharmaceutical Care Management Association (PCMA) in Rutledge v. PCMA could have a negative impact on costs and patient outcomes. According to a press release, the case […]

more info 04/03/2020View Related Articles
Bookmark and Share

MSK’s Bach Talks High-Value Drug Development

Memorial Sloan Kettering Cancer Center's Dr. Peter Bach in a recent interview with Liam Bendicksen discusses ways to optimize high-value drug development. Bach said while it's a complex effort, the goal is to pay as little as possible to pharmaceutical companies to "incentivize high-value […]

more info 04/02/2020View Related Articles
Bookmark and Share

ISPOR Task Force Publishes New Good Practices Reports

The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) Value of Information Analysis Emerging Good Practices Task Force has had two good practices reports published in Value in Health since February. The following are the published reports: Value of Information […]

more info 04/01/2020View Related Articles
Bookmark and Share

Calculating Costs, Benefits of Lockdowns

How do economists calculate the value of preventing COVID-19 deaths? The authors of a recent article published on Forbes outline the methods economists use to project the potential impact on costs. While putting a dollar amount on a human life may make some "uncomfortable," the authors write, […]

more info 03/31/2020View Related Articles
Bookmark and Share

PRMA’s Chadwick Talks Digital Tech’s Impact on Market Access

PRMA Consulting HTA Manager Claire Chadwick outlines how digital technology is changing the face of the market access landscape in the latest tHEORetically Speaking blog post. HealthEconomics.Com LLC CEO and HE Institute Principal Researcher Patti Peeples conducted the interview. Chadwick […]

more info 03/30/2020View Related Articles
Bookmark and Share

Article Outlines How Health Plans Utilize RWE for Specialty Drug Coverage

Health plans' use of real-world evidence for specialty drug coverage decisions is generally varied in terms of the number and type of studies cited, according to a recent article published by Wiley. The authors, Ari Panzer et al., used data from the Tufts Medical Center Specialty Drug Evidence […]

more info 03/30/2020View Related Articles
Bookmark and Share

Waystar: Poor Price Transparency is ‘Single Biggest Issue’ in Patient’s Financial Experience

In a sponsored article on HealthLeaders Media, Waystar outlines the patient's need for more "financial clarity" during their health care journey. Waystar points to a 2019 published in JAMA which suggests it's becoming more likely for patients to be billed by an out-of-network provider despite […]

more info 03/27/2020View Related Articles
Bookmark and Share

eyeforpharma Philadelphia Pivots to Virtual Event

In response to the COVID-19 outbreak, eyeforpharma is transitioning its eyeforpharma Philadelphia conference to a free, online event. The 4-day virtual conference is set to kick off April 14, and will feature more than 70 sessions and more than 70 speakers. "The Covid-19 coronavirus has […]

more info 03/26/2020View Related Articles
Bookmark and Share

NICE Publishes COVID-19 Guidelines

The National Institute for Health and Care Excellence (NICE) on March 21 published a new set of guidelines that address the management of patients with COVID-19, and those without. NICE says the guidelines aim to bolster patient safety, as well as facilitate the "best use of NHS resources and […]

more info 03/25/2020View Related Articles
Bookmark and Share

Webinar – Faster to Market: Transforming HEOR & RWE Using Virtual Sourcing

Wish you could get HEOR & RWE projects started faster, cheaper, & using the most optimal vendor? Do you want to connect with new buyers in this age of reduced face-to-face business development? Some of the biggest challenges in HEOR & RWE are long contracting time, lack of RFI […]

more info 03/23/2020View Related Articles
Bookmark and Share

Blog Post Mulls Indirect Benefits in Value Assessments

A recent blog post published on Health Affairs highlights some key reasons why indirect benefits should be factored into value assessments. The authors, National Pharmaceutical Council Vice President of Research Michael Ciarametaro et al., suggest indirect benefits in value assessments have "the […]

more info 03/23/2020View Related Articles
Bookmark and Share

Predictions for RWE in 2020

A recent article published on PharmaTimes looks at what the future may hold for real-world evidence amid rising interest in the pharmaceutical industry. The author, Verantos CEO Dan Riskin, widespread efforts to establish robust RWE "provides a significant opportunity to refine the standard of […]

more info 03/21/2020View Related Articles
Bookmark and Share

Lin: Clinical Practice Guidelines Not Broken

Family physician and Common Sense Family Doctor blogger Kenneth Lin in a recent post published on MedPage Today writes that while "clinical practice guidelines have problems, they're not broken." Lin was referencing the title of a Health Affairs blog post, "Fixing Clinical Practice Guidelines," […]

more info 03/20/2020View Related Articles
Bookmark and Share

ICER Indefinitely Postpones Public Meetings, Expands Assessment Timelines

In response to the COVID-19 pandemic, the Institute for Clinical and Economic Review (ICER) announced it would indefinitely postpone several public meetings and push out the timelines for assessments. The following details were provided in a press release sent out Wednesday morning: Sickle […]

more info 03/18/2020View Related Articles
Bookmark and Share

AMCP Cancels Annual Meeting

The Academy of Managed Care Pharmacy (AMCP) has canceled its annual meeting, which was set to begin April 21, saying that holding the meeting amid the COVID-19 outbreak has "become impermissible." "We deeply appreciate your patience as AMCP leaders and staff have monitored and responded to this […]

more info 03/17/2020View Related Articles
Bookmark and Share

Pfizer Offers Its Resources in Fight Against Coronavirus

Pfizer is entering the fight against coronavirus after announcing it would offer its resources for wider use, FiercePharma reports. The drugmaker is also calling on other drugmakers to collaborate, according to the report. "Pfizer calls on all members of the innovation ecosystem—from large […]

more info 03/16/2020View Related Articles
Bookmark and Share

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 34
  • Next Page

 

View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Conference of the Week:

Link of the Week:

Job of the Week:

Webinar of the Week:

White Papers

  • Pragmatic Randomized Trials: Considerations for Design and Implementation
  • Current Landscape: Value Assessment Frameworks
  • The New Health Economy is Here. Do You Have the Right Knowledge Resources in Place?
  • The Link Between Drug Prices and Research on the Next Generation of Cures
  • Social Determinants of Health: The Impact on Members, Health Outcomes and the Bottom Line
  • Leveraging Technology to Reduce Costs in Clinical Trials
  • Evidence Generation and Communication
  • Medical Cost Trend: Behind the Numbers 2020
  • Harnessing the Power of Nontraditional Data in Health Care
  • Global Oncology Trends 2019
  • Medical Affairs Reputations: Migraine (US) 2019
  • A Multistakeholder Discussion on Open Access and Medical Publishing
  • 2018 Specialty Drug Trends
  • The Global Use of Medicine in 2019 and Outlook to 2023
  • Breaking Through the Hype of Real-World Evidence
  • Time to Market: Accelerating Market Access
  • Orphan Drugs in the United States
  • Charting Real World Data and Evidence – Activity and Capabilities (2018)
  • From Patent to Patient: Analyzing Access to Innovative Cancer Drugs
  • Transitioning Payment Models: Fee-for-Service to Value-Based Care
  • How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions
  • Generating Consensus and Trust for Quality Measurement to Support Value-Based Care
  • An Evidence-Based Approach to Hiring: Leaders, Physicians, Nurses, and Front Line Staff
  • Big Data in Pharmaceuticals: Big Opportunities or Big Challenges – or Both?
  • AHIP Executive Roundtable Discussion Summary
  • It Takes Two to Tango
  • Real World Data Capabilities: Benchmarking Pharma Companies
  • Health Care USA: A Cancer on the American Dream
  • The Utility of ICER Reports for Private Payer Drug Coverage Decision-Making: Cost-Effectiveness Assessments
  • Advancing Biosimilar Sustainability in Europe

Syndicated Reports

  • Comparing Medical Affairs Teams Head to Head
  • Building Effective Health Economic Outcomes Research (HEOR) Teams
  • Patient Reported Outcomes: Strategies for Market Access
  • Refining the Commercial Exchange Risk-Adjustment Model
  • How Can Pharma Ensure Positive Payer Support With it’s Pricing?
  • AccessPoint: Expanding the Impact of RWE
  • Market Access: Department Models and Structures
  • Do the Benefits of RBM Outweigh the Risks?
  • How do Companies Decide on PROs Delivery Mechanisms?
  • Orphan Drug Report 2014 Download
  • Download EvaluatePharma Orphan Drug Report 2015
  • Biosimilars: Regulatory Outlook
  • Final Report Released on Controversies in Obesity Management
  • Fortify Payer Relationships to Secure Product Profitability
  • Your Free Report From AIS’s Rx Benefit Data.
  • See Cutting Edge Report On Health Economics For Medical Devices Here!
  • European Payer Perspectives On Biosimilars
  • Will The Majority Of Future Drugs Meet Orphan Drug Criteria?
  • Specialty Pharmacy Trends Report: Oncology
  • Healthcare Models, Measures and Methodology – 97 FAQs
  • What Are The Greatest challenges And Opportunities For Biosimilars In Emerging Markets?
  • Market Access Policy Relationships – Comparing Germany and France
  • ASCO 2014 — Delegate Physicians Rate Influence and Impact
  • Oncology Market Access Europe – Payer and Industry Perspectives
  • Medical Affairs Reputations In Oncology: Oncologists Rate Key Products and Companies
  • The Future of Cancer Immunotherapy: KOL Views Bring Opportunities Into Sharp Focus
  • Biosimilar Index: Tracking the Biosimilar Development Landscape
  • Reshaping Medical Affairs: Delivering Value to KOLs and Payers
  • Market Access Team Management: Driving Exceptional Performance
  • Are You Managing Your Market Access Team For Success?
HealthEconomics.Com

HealthEconomics.Com

  • Become a Better Writer!
  • HealthEconomics.Com Recognized as Top Influencer at ISPOR International Meeting in Washington DC
  • Will ICER Framework Destroy Progress Against Multiple Myeloma?
  • Celgene Unleashes the Power of Data into Clinical Trial Design
  • How Well is Harvoni Working in the Real World?
  • New CVS and Express Scripts Value Based Plans for Oncology
  • Oversized Cancer Drug Vials Waste $3B Each Year
  • Can More Data Make Providers’ Jobs Easier?
  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Take This Survey for a Chance to Win $200!
  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • ICER Releases Two Draft Reports on Obeticholic Acid
  • What do Patient Advocates Think of New ICER Report?
  • Could a New ICER Report Put Patients at Risk?
  • Contact Us

About

  • International Myeloma Foundation Responds to ICER Report
  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HE Institute

Strategy, Training, Education, and Communications in HEOR & Market Access.

Innovation Webinar

Big ideas accelerating change in HEOR, RWE and Health Technology. Learn more!

tHEORetically Speaking Blog

Insights and observations for HEOR, market access, pricing, reimbursement, and health policy.

HE Jobs Portal

Your Premier Employment Source for HEOR, Market Access, and Real World Evidence

HE Webinars

Online educational and informational seminars for HEOR, market access, pricing, and reimbursement.
  • Doctor Evidence Launches GROWTH Replicator Program
  • Is PCORI Underfunding CER?
  • HealthEconomics.Com
  • About HealthEconomics.Com
  • Advertising Inquiries
  • Careers
  • Contact HealthEconomics.Com

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • Will Improving Adherence Optimize Medication Use?
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • The HEOR & RWE Marketplace
    • Visit the Market Place
    • On-demand Webinar
  • Industry Events
    • 5 Tips for Trade Show Success
    • HE Innovation Webinar
    • Webinar Services from HealthEconomics.Com
    • View Conferences
    • View Webinars
    • View Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
  • HE Institute